Live
Endpoints NewsSeaport and Hemab file for IPOs, with Kailera expected to price soonIlluminaDoes Illumina (ILMN) Now Offer Value After A 61.7% One Year Rebound? - simplywall.stIlluminaIllumina (ILMN), Labcorp (LH) Expand Precision Oncology NGS Collaboration - Yahoo FinanceLonza NewsLonza Group AG stock (CH0013841017): Is its biopharma contract dominance strong enough to unlock new - AD HOC NEWSFierceBiotechGSK CEO's 'scientific courage' propels plans for medley of phase 3 trials for Hansoh-partnered ADCEndpoints NewsGSK plans five Phase 3 studies for gynecological cancer ADC from HansohIlluminaIllumina Inc. stock (US4523271090): Is its genomics leadership strong enough for long-term U.S. inve - AD HOC NEWSAgilentTRADE NEWS: Agilent Technologies to Demonstrate Leading-Edge RF/Microwave Design and Test Solutions - YahooThermo FisherIs Thermo Fisher Scientific (TMO) Pricing Look Stretched After Recent Share Price Rebound - simplywall.stIlluminaIs It Time To Reassess Illumina (ILMN) After Its 61.7% One Year Share Price Rebound - Yahoo FinanceThermo FisherWallace Advisory Group Reduces Stake in Thermo Fisher Scientific - National Today10x Genomics Blog10X Genomics Opens with 6.32% Gain, Outperforming S&P 500's 2.51% Increase - Markets Mojo
Endpoints News Apr 13, 2026

Seaport and Hemab file for IPOs, with Kailera expected to price soon

Seaport and Hemab file for IPOs, with Kailera expected to price soon

Original
Body unavailable. Use the original source.

Directory

59 All